Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Owen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of the American Pharmacists Association : Japha|September 6, 2016
Developing a vision and strategic action plan for future community-based residency trainingJann B Skelton, James A Owen
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 5, 2002
Quetiapine blood level variabilityIngrid Savasi, Richard C Millson, James A Owen
Pharmacy (Basel, Switzerland)|September 4, 2020
Advancing the Adoption of Continuing Professional Development (CPD) in the United StatesJames A Owen, Jann B Skelton, Lucinda L Maine
The American Journal of Psychiatry|April 2, 2002
Topiramate for refractory schizophreniaRichard C Millson, James A Owen, Gunter W Lorberg, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2013
Patient care services provided at primary community pharmacy residency sitesJon C Schommer, James A Owen, Gina M Scime, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 28, 2006
Effects of oral racemic citalopram on neuroendocrine responsesEmily R Hawken, James A Owen, Dean Van Vugt, et al.
Psychopharmacology|August 8, 2009
Specific effects of escitalopram on neuroendocrine responseEmily R Hawken, James A Owen, Robert W Hudson, et al.
American Journal of Pharmaceutical Education|June 22, 2019
The Need for Faculty Knowledge and Promotion of Postgraduate Year One Community-Based Pharmacy ResidenciesJean-Venable R Goode, Marialice S Bennett, Anne L Burns, et al.
Journal of the American Pharmacists Association : Japha|November 1, 2020
Pharmacist-initiated treatment of minor conditions: A call to actionAlexis Page, James A Owen, Jean-Venable R Goode, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2002
Effects of clonidine in schizophrenic patients with primary polydipsia: three single case studiesNicholas J Delva, Anna Chang, Emily R Hawken, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of the American Pharmacists Association : Japha|September 6, 2016
Developing a vision and strategic action plan for future community-based residency trainingJann B Skelton, James A Owen
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 5, 2002
Quetiapine blood level variabilityIngrid Savasi, Richard C Millson, James A Owen
Pharmacy (Basel, Switzerland)|September 4, 2020
Advancing the Adoption of Continuing Professional Development (CPD) in the United StatesJames A Owen, Jann B Skelton, Lucinda L Maine
The American Journal of Psychiatry|April 2, 2002
Topiramate for refractory schizophreniaRichard C Millson, James A Owen, Gunter W Lorberg, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2013
Patient care services provided at primary community pharmacy residency sitesJon C Schommer, James A Owen, Gina M Scime, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 28, 2006
Effects of oral racemic citalopram on neuroendocrine responsesEmily R Hawken, James A Owen, Dean Van Vugt, et al.
Psychopharmacology|August 8, 2009
Specific effects of escitalopram on neuroendocrine responseEmily R Hawken, James A Owen, Robert W Hudson, et al.
American Journal of Pharmaceutical Education|June 22, 2019
The Need for Faculty Knowledge and Promotion of Postgraduate Year One Community-Based Pharmacy ResidenciesJean-Venable R Goode, Marialice S Bennett, Anne L Burns, et al.
Journal of the American Pharmacists Association : Japha|November 1, 2020
Pharmacist-initiated treatment of minor conditions: A call to actionAlexis Page, James A Owen, Jean-Venable R Goode, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2002
Effects of clonidine in schizophrenic patients with primary polydipsia: three single case studiesNicholas J Delva, Anna Chang, Emily R Hawken, et al.
Pageof 2